IBB Industry Partners Video

Established in 1994, the program covers a broad spectrum of interdisciplinary research including regenerative medicine and pharmaceutical disciplines.
Members in the fee-based program ranging from small companies to large, multi-national corporations, may derive benefits in the following ways.
The Program is designed to maximize the intellectual exchange between industry, faculty and students and allows companies to keep an eye on the latest advances in biomedical engineering and bioscience that will impact patient care in the future.

Category:

Science & Technology

Tags:

• Georgia Tech
• Technology Transfer
• IBB
• Innovation